News
CTVA
54.71
-0.69%
-0.38
Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last?
NASDAQ · 18h ago
Corteva, Inc.'s (NYSE:CTVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Corteva (NYSE:CTVA) has a return on equity of 3.7%. The company has grown its net income at a rate of 69% over the last five years. Corteva's ROE is better than the industry average of 13%. We look at the company's profitability to assess its ability to reinvest in the market. The company's ROe is in line with its earnings growth. Corteva is up 15% in the last three months.
Simply Wall St · 20h ago
Weekly Report: what happened at CTVA last week (0311-0315)?
Weekly Report · 21h ago
FMAT: Materials Sector Dashboard For March
Seeking Alpha · 4d ago
Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast
Corteva, Inc. Will release its first quarter 2024 earnings on Wednesday, May 1, 2024. The earnings will be presented in a live webcast on Thursday, May 2, 2024, at 9:00 a.m. Eastern Time. Corteva is a global pure-play agriculture company.
PR Newswire · 5d ago
Weekly Report: what happened at CTVA last week (0304-0308)?
Weekly Report · 03/11 09:20
RBC Capital Sticks to Their Buy Rating for Corteva (CTVA)
TipRanks · 03/08 01:45
Corteva, Inc. (CTVA) Gains But Lags Market: What You Should Know
NASDAQ · 03/07 23:15
Loop Capital Markets upgrades Corteva (CTVA) to a Buy
TipRanks · 03/07 15:15
Added Corteva To Our Model Portfolio (Technical Analysis)
Seeking Alpha · 03/06 18:05
Searching for Value Stocks? Wall Street Analyst Recommends 3 Picks in the Materials Sector
The materials sector has underperformed the S&P over the past 12 months. But Wolfe Research analyst Chris Parkinson says the sector is still a top choice for value investors. He names three materials stocks to buy now. The company of agricultural materials and chemicals, Corteva, is one of these three stocks.
TipRanks · 03/05 10:50
Weekly Report: what happened at CTVA last week (0226-0301)?
Weekly Report · 03/04 09:20
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant
TipRanks · 03/02 01:45
Expert Ratings For Corteva
Corteva is an agriculture pure play that was spun off from DowDuPont. The average price target for Corteva is $60.78. 9 analysts have evaluated Corteva and provided 12-month price targets. The company is a leader in the development of new seed and crop chemicals products.
Benzinga · 03/01 20:02
Corteva Initiated at Outperform by Wolfe Research
Dow Jones · 03/01 17:50
Kimberly-Clark factory where Kleenex made pollutes town with PFAS, lawsuit says
Kimberly-Clark factory where Kleenex made pollutes town with PFAS, lawsuit says Residents say Connecticut facility contaminated their water, land Lawsuit seeks order to install filters and establish medical fund. A spokesperson for Kimberly-Clark said the company believes the lawsuit is "unfounded"
Reuters · 02/29 20:58
Corteva, Inc. (NYSE:CTVA) is largely controlled by institutional shareholders who own 82% of the company
Institutional investors own 82% of Corteva, Inc. (NYSE:CTVA) The company is owned by institutions and the top 17% of the company's shares are held by institutional investors. The company's ownership of 50% suggests the company has a significant influence over the share price. The majority of shares are owned by the institutions. Corteva is not a good investment for those who want to see the long-term growth of the business. It's worth looking at the insider ownership of the firm to see what impact it may have on shareholders.
Simply Wall St · 02/29 10:19
Press Release: Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements. The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates. Lavie Bio is a subsidiary of Evogene Ltd.
Dow Jones · 02/28 12:00
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates. Lavie Bio Ltd. Is a subsidiary of Evogene Ltd. The company has successfully secured the second-half advance payment of $2.5 million after meeting Corteva's licensing agreement requirements.
PR Newswire · 02/28 12:00
Ex-Dividend Reminder: C.H. Robinson Worldwide, Walker & Dunlop and Corteva
NASDAQ · 02/27 15:39
More
Webull provides a variety of real-time CTVA stock news. You can receive the latest news about Corteva Inc through multiple platforms. This information may help you make smarter investment decisions.
About CTVA
Corteva, Inc. is a global pure-play agriculture company. The Company is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier food supply. The Company's Seed segment is developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is engaged in the seed markets, such as North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa, and Argentina corn. The segment also offers trait technologies that improve resistance to weather, disease, insects and enhance food. The Company's Crop Protection segment offers crop protection solutions and digital solutions that provide farmers with the tools they need to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment offers herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals.